Back to search results
NCT06593860

Dysarthria Management for Minor Groups

Active, Not Recruiting
NAAges 25–85InterventionalTreatment
Florida State University
~32 participants
Updated 2026-06-03 on ClinicalTrials.gov
What's tested:Remote speech rehabilitation

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Speech Intelligibility Score on a Visual Analogue Scale
Measured over Immediately after and 6 months after treatment
+2 more outcomes measured

Conditions

Parkinson Disease
Dysarthria

Explore related trials

DysarthriaParkinson Disease

NCT06593860

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Florida State University

    Tallahassee, Floridano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Yunjung Kim · PRINCIPAL_INVESTIGATOR · Florida State University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Medical diagnosis of PD
No history of other neurological disease
Native speaker of Korean
Age between 25 and 85
Diagnosis of dysarthria secondary to PD from an SLP
Self-reported typical hearing
Access to high-speed internet for therapy sessions

Exclusion

A score of 23 or below on the Korean Montreal Cognitive Assessment
Evidence of voice-speech disorders not-related to PD
Received speech therapy for PD-related problems in the past one year
Have no family members to participate in the project.

What this trial measures

  • Speech Intelligibility Score on a Visual Analogue ScaleImmediately after and 6 months after treatment

    Speech intelligibility will be estimated using the visual analogue scale method. Listeners will rate the degree to which they understood the speech recordings on a continuous line. The two ends will be labeled, totally unintelligible and completely intelligible, respectively. Higher scores indicate more intelligible.

  • Vowel Space Area (kHz)Immediately after and 6 months after treatment

    Two acoustic measures will be measured as Primary Outcome. The first one is the size of vowel space area, which has been frequently reported to correlate with speech intelligibility in people with Parkinson's disease.

  • Speaking Rate (syl/s)Immediately after and 6 months after treatment

    The second acoustic measures to be included as Primary Outcome is speaking rate. This will be reported as the number of syllables produced in one second.